Literature DB >> 11714529

A case-control study of lung cancer screening in Okayama Prefecture, Japan.

K Nishii1, H Ueoka, K Kiura, T Kodani, M Tabata, T Shibayama, K Gemba, T Kitajima, A Hiraki, M Kawaraya, T Nakayama, M Harada.   

Abstract

The effectiveness of lung cancer screening in reducing mortality still remains uncertain. In order to evaluate the efficacy of lung cancer screening, a case-control study was conducted in Okayama Prefecture, Japan. The study area consisted of 34 municipalities where a population-based lung cancer screening had been conducted. Chest X-ray examinations for all participants and sputum cytology for high-risk participants were offered annually. The cases analyzed in this study consisted of 412 individuals aged between 40 and 79 who died of lung cancer. A total of 3490 controls, two to ten for each case matched by gender, year of birth, and living district were randomly collected. Screening histories of cases were compared with those of and matched controls for the identical calendar period prio to diagnosis of the case. Smoking adjusted odds ratio (OR) of death from lung cancer for screened individuals versus unscreened, within 12 months before diagnosis, was calculated as 0.59 (95% confidence interval: 0.46-0.74; P=0.0001). The OR for women (0.39, 95% confidence interval: 0.24-0.64) was lower than that for men (0.67, 95% confidence interval: 0.51-0.87), although both were statistically significant. These results suggest that lung cancer screening contributes to reducing lung cancer mortality by 41%.

Entities:  

Mesh:

Year:  2001        PMID: 11714529     DOI: 10.1016/s0169-5002(01)00270-7

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  8 in total

Review 1.  Lung cancer screening.

Authors:  Peter J Mazzone; Tarek Mekhail
Journal:  Curr Oncol Rep       Date:  2007-07       Impact factor: 5.075

2.  Pulmonary nodules 10 mm or less in diameter with ground-glass opacity component detected by high-resolution computed tomography have a high possibility of malignancy.

Authors:  Hyung-Eun Yoon; Kenjiro Fukuhara; Toshiya Michiura; Minoru Takada; Masami Imakita; Kentaro Nonaka; Kazuhiro Iwase
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2005-01

Review 3.  Lung cancer screening and its efficacy.

Authors:  Motoyasu Sagawa; Katsuo Usuda; Hirokazu Aikawa; Yuichiro Machida; Makoto Tanaka; Masakatsu Ueno; Tsutomu Sakuma
Journal:  Gen Thorac Cardiovasc Surg       Date:  2009-10-16

4.  A population-based cohort study of chest x-ray screening in smokers: lung cancer detection findings and follow-up.

Authors:  Lorenzo Dominioni; Nicola Rotolo; William Mantovani; Albino Poli; Salvatore Pisani; Valentina Conti; Massimo Paolucci; Fausto Sessa; Antonio Paddeu; Vincenzo D'Ambrosio; Andrea Imperatori
Journal:  BMC Cancer       Date:  2012-01-17       Impact factor: 4.430

5.  Incidental esophageal submucosal tumor detection by chest radiography: A case report.

Authors:  Sosuke Tadano; Tadashi Kondo; Muneaki Watanabe; Norio Takayashiki; Toshihiro Shiozawa; Gen Ohara; Kastunori Kagohashi; Koichi Kurishima; Hiroaki Satoh
Journal:  Exp Ther Med       Date:  2014-10-08       Impact factor: 2.447

6.  The Prefectural Participation Rates of Lung Cancer Screening Had a Negative Correlation with the Lung Cancer Mortality Rates

Authors:  Motoyasu Sagawa; Ryoko Machii; Tomio Nakayama; Takafumi Sugawara; Naoya Ishibashi; Hideki Mitomo; Takashi Kondo; Toshiharu Tabata
Journal:  Asian Pac J Cancer Prev       Date:  2019-03-26

7.  Surveillance of chronic obstructive pulmonary disease in high-risk individuals by using regional lung cancer mass screening.

Authors:  Yasuo Sekine; Ryoko Yanagibori; Kiminori Suzuki; Sonomi Sugiyama; Haruko Yamaji; Michiko Ishibashi; Takehiko Fujisawa
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-06-23

8.  The Effect of False-Positive Results on Subsequent Participation in Chest X-ray Screening for Lung Cancer.

Authors:  Akira Sato; Shota Hamada; Yuki Urashima; Shiro Tanaka; Hiroaki Okamoto; Koji Kawakami
Journal:  J Epidemiol       Date:  2016-07-02       Impact factor: 3.211

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.